Andretti Acquisition (POLE) Cash & Equivalents (2024 - 2026)
Andretti Acquisition's (POLE) quarterly Cash & Equivalents came in at $150516.0 in Q1 2026, down 75.43% YoY from $612692.0 in Q1 2025, and up 210.54% on a QoQ basis from $48469.0 in Q4 2025.
Powered by 
Analysis
Andretti Acquisition (POLE) Cash & Equivalents (2024 - 2026) Analysis & Trends
Andretti Acquisition (POLE) has 3 years of Cash & Equivalents data on file, last reported at $150516.0 in Q1 2026.
- Quarterly Cash & Equivalents fell 75.43% year-over-year to $150516.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150516.0 (down 75.43% YoY) and the FY2025 annual result came in at $48469.0, down 93.93% from the prior year.
- Cash & Equivalents improved to $150516.0 in Q1 2026, from $48469.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $798454.0 in Q4 2024 to a low of $48469.0 in Q4 2025.
- A 3-year average of $386594.7 and a median of $354718.5 in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2025 — Cash & Equivalents tumbled 93.93% — and 2026, when it sank 75.43%.
- Tracing POLE's Cash & Equivalents over 3 years: stood at $798454.0 in 2024, then plunged by 93.93% to $48469.0 in 2025, then jumped by 210.54% to $150516.0 in 2026.
- The last three Cash & Equivalents figures came in at $150516.0 (Q1 2026), $48469.0 (Q4 2025), and $250000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 250,000.00 |
| 3 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | 54,503.00 |
| 4 | Fifth Era Acquisition Corp I | 657.23 Mn | 657.23 Mn | - | 157,686.00 |
| 5 | Andretti Acquisition | 656.30 Mn | 656.30 Mn | - | 225,380.00 |
| 6 | Oxley Bridge Acquisition | 652.74 Mn | 652.74 Mn | - | 729,941.00 |
| 7 | Drugs Made In America Acquisition | 647.83 Mn | 647.83 Mn | - | 174,974.00 |
| 8 | Launch Two Acquisition | 621.00 Mn | 621.00 Mn | - | 23,197.00 |
| 9 | Launch One Acquisition | 620.42 Mn | 620.42 Mn | - | 321,957.00 |
| 10 | GSR IV Acquisition | 601.64 Mn | 601.64 Mn | - | 643,331.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 225,380.00 |
| Mar 31, 2026 | 250,000.00 |
| Dec 31, 2025 | 48,469.00 |
| Sep 30, 2025 | 250,000.00 |
| Jun 30, 2025 | 459,437.00 |
| Mar 31, 2025 | 612,692.00 |
| Dec 31, 2024 | 798,454.00 |